Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 49 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 67 | 2,336−3.9%/yr | −3.9%/yr | 4.61.7× | 1% | 2,600 in 2030+1.8%/yr |
| Decompression & minimally invasive spine | 51 | 2,105−5.5%/yr | −5.5%/yr | 4.21.3× | 5% | 2,480 in 2030+2.7%/yr |
| Cervical fusion & disc arthroplasty | 24 | 1,147−1.6%/yr | −1.6%/yr | 2.31.9× | 1% | 1,280 in 2030+1.9%/yr |
| Kyphoplasty & vertebroplasty | 0 | 538−5.5%/yr | −5.5%/yr | 1.11.2× | 18% | 560 in 2030+0.6%/yr |
| SI joint fusion | 9 | 330+20%/yr | +20%/yr | 0.63.1× | 11% | 570 in 2030+9.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 177 | 30,092−2.5%/yr | −2.5%/yr | 58.80.6× | 48% | 33,000 in 2030+1.5%/yr |
| Skin substitutes & wound grafts | 27 | 6,374+23%/yr | +23%/yr | 7.80.6× | 82% | 11,000 in 2030+9.5%/yr |
| Bone graft & orthobiologics | 10 | 513−4.9%/yr | −4.9%/yr | 1.01.3× | 3% | 590 in 2030+2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 95 | 6,258+2.1%/yr | +2.1%/yr | 12.21.3× | 84% | 8,230 in 2030+4.7%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 10 | 515+13%/yr | +13%/yr | 1.01.1× | 55% | 1,080 in 2030+13%/yr |
| Spinal cord & DRG stimulation | 6 | 257−4.5%/yr | −4.5%/yr | 0.50.8× | 65% | 390 in 2030+7.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Superficial venous ablation | 41 | 3,790+0.3%/yr | +0.3%/yr | 7.41.3× | 99% | 5,330 in 2030+5.9%/yr |
| Dialysis access | 23 | 1,386−15%/yr | −15%/yr | 3.00.6× | 39% | 1,300 in 2030−1.1%/yr |
| Peripheral arterial intervention | 6 | 1,107−8.7%/yr | −8.7%/yr | 2.20.4× | 43% | 1,830 in 2030+8.7%/yr |
| Thrombectomy, IVC filters & venous stents | 4 | 635+0.4%/yr | +0.4%/yr | 1.31.1× | 18% | 790 in 2030+3.6%/yr |
| Carotid revascularization | 5 | 302−7.5%/yr | −7.5%/yr | 0.60.7× | 0% | 280 in 2030−1.5%/yr |
| Aortic endografts (EVAR/TEVAR) | 0 | 174−6.8%/yr | −6.8%/yr | 0.41.1× | 0% | 200 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 52 | 3,413−0.2%/yr | −0.2%/yr | 7.41.3× | 11% | 3,950 in 2030+2.5%/yr |
| Cholecystectomy & appendectomy | 18 | 1,923−3.3%/yr | −3.3%/yr | 4.11.1× | 3% | 2,250 in 2030+2.6%/yr |
| Colorectal resection | 2 | 764−2.7%/yr | −2.7%/yr | 1.61.1× | 0% | 860 in 2030+2.1%/yr |
| Antireflux & hiatal hernia surgery | 10 | 529+3.9%/yr | +3.9%/yr | 1.11.6× | 0% | 750 in 2030+6.1%/yr |
| Breast reconstruction | 0 | 223−9.1%/yr | −9.1%/yr | 0.51.1× | 0% | 230 in 2030+0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 49 | 2,851−4%/yr | −4%/yr | 5.81.3× | 43% | 2,530 in 2030−2%/yr |
| Kidney stone management | 50 | 2,035+0.6%/yr | +0.6%/yr | 4.21.2× | 23% | 2,670 in 2030+4.6%/yr |
| Incontinence, prolapse & sacral neuromodulation | 21 | 1,253+1.4%/yr | +1.4%/yr | 2.61.4× | 19% | 1,570 in 2030+3.8%/yr |
| Hysterectomy, hysteroscopy & ablation | 11 | 1,230+1.8%/yr | +1.8%/yr | 2.81.2× | 8% | 1,580 in 2030+4.2%/yr |
| Prostatectomy & nephrectomy | 9 | 636−1.1%/yr | −1.1%/yr | 1.41.2× | 0% | 690 in 2030+1.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 19 | 2,002−1.7%/yr | −1.7%/yr | 4.20.9× | 85% | 2,650 in 2030+4.8%/yr |
| Cochlear implants | 4 | 157+3.7%/yr | +3.7%/yr | 0.32.0× | 0% | 110 in 2030−5.3%/yr |
| Sleep apnea & airway implants | 3 | 136+11%/yr | +11%/yr | 0.31.9× | 0% | 110 in 2030−3.7%/yr |
| Ear tubes & middle ear surgery | 0 | 101−5.6%/yr | −5.6%/yr | 0.21.0× | 100% | 110 in 2030+2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 51 | 3,013−3.3%/yr | −3.3%/yr | 6.61.0× | 36% | 3,380 in 2030+1.9%/yr |
| Tumor & fibroid embolization | 4 | 415+7.6%/yr | +7.6%/yr | 0.91.6× | 70% | 820 in 2030+12%/yr |
| Tumor ablation | 0 | 122−2.6%/yr | −2.6%/yr | 0.30.9× | 0% | 150 in 2030+3.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 85 | 11,013+29%/yr | +29%/yr | 22.21.1× | 86% | 21,300 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| EP ablation | 47 | 2,229+6.8%/yr | +6.8%/yr | 3.81.3× | 0% | 4,850 in 2030+14%/yr |
| Pacemaker, ICD & CRT implantation | 38 | 1,903−1.6%/yr | −1.6%/yr | 4.11.0× | 0% | 2,210 in 2030+2.5%/yr |
| LAA occlusion & loop recorders | 39 | 1,871+12%/yr | +12%/yr | 3.31.2× | 4% | 4,220 in 2030+15%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 63 | 2,688−3.7%/yr | −3.7%/yr | 4.51.0× | 1% | 3,050 in 2030+2.1%/yr |
| Structural heart (TAVR, TEER) | 33 | 787+4.2%/yr | +4.2%/yr | 1.30.9× | 0% | 1,130 in 2030+6.3%/yr |
| Mechanical circulatory support | 0 | 158−8.8%/yr | −8.8%/yr | 0.30.7× | 0% | 190 in 2030+3.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| DBS & VNS | 5 | 282−2.4%/yr | −2.4%/yr | 0.61.8× | 14% | 540 in 2030+12%/yr |
| Aneurysm & intracranial embolization | 6 | 214+15%/yr | +15%/yr | 0.40.9× | 0% | 430 in 2030+12%/yr |
| Stroke thrombectomy | 7 | 194+4.9%/yr | +4.9%/yr | 0.41.0× | 0% | 180 in 2030−1.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 127 | 26,813−0.4%/yr | −0.4%/yr | 54.01.2× | 87% | 31,400 in 2030+2.7%/yr |
| Vitreoretinal surgery | 31 | 1,941+1%/yr | +1%/yr | 4.01.6× | 75% | 2,470 in 2030+4.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 277 | 51,857−1.4%/yr | −1.4%/yr | 110.71.1× | 57% | 56,700 in 2030+1.5%/yr |
| ERCP & endoscopic ultrasound | 25 | 1,932+0.7%/yr | +0.7%/yr | 4.11.2× | 0% | 2,030 in 2030+0.9%/yr |
| Bronchoscopy & lung nodule | 18 | 1,328+5.9%/yr | +5.9%/yr | 2.81.1× | 0% | 2,020 in 2030+7.2%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.